SE9502921D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9502921D0
SE9502921D0 SE9502921A SE9502921A SE9502921D0 SE 9502921 D0 SE9502921 D0 SE 9502921D0 SE 9502921 A SE9502921 A SE 9502921A SE 9502921 A SE9502921 A SE 9502921A SE 9502921 D0 SE9502921 D0 SE 9502921D0
Authority
SE
Sweden
Prior art keywords
pct
new compounds
sec
preparation
date
Prior art date
Application number
SE9502921A
Other languages
English (en)
Inventor
Ralph Brattsand
Rikard Holmdahl
Liselotte Jansson
Valerija Loncar
Lars Pettersson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9502921A priority Critical patent/SE9502921D0/sv
Publication of SE9502921D0 publication Critical patent/SE9502921D0/sv
Priority to US08/817,683 priority patent/US6043236A/en
Priority to CA002228803A priority patent/CA2228803A1/en
Priority to JP9510174A priority patent/JPH11511457A/ja
Priority to PCT/SE1996/001028 priority patent/WO1997008188A1/en
Priority to EP96928771A priority patent/EP0847399A1/en
Priority to AU68405/96A priority patent/AU6840596A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9502921A 1995-08-23 1995-08-23 New compounds SE9502921D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9502921A SE9502921D0 (sv) 1995-08-23 1995-08-23 New compounds
US08/817,683 US6043236A (en) 1995-08-23 1996-08-20 Estrogens
CA002228803A CA2228803A1 (en) 1995-08-23 1996-08-20 Novel estrogens
JP9510174A JPH11511457A (ja) 1995-08-23 1996-08-20 新規エストロゲン
PCT/SE1996/001028 WO1997008188A1 (en) 1995-08-23 1996-08-20 Novel estrogens
EP96928771A EP0847399A1 (en) 1995-08-23 1996-08-20 Novel estrogens
AU68405/96A AU6840596A (en) 1995-08-23 1996-08-20 Novel estrogens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502921A SE9502921D0 (sv) 1995-08-23 1995-08-23 New compounds

Publications (1)

Publication Number Publication Date
SE9502921D0 true SE9502921D0 (sv) 1995-08-23

Family

ID=20399257

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502921A SE9502921D0 (sv) 1995-08-23 1995-08-23 New compounds

Country Status (7)

Country Link
US (1) US6043236A (sv)
EP (1) EP0847399A1 (sv)
JP (1) JPH11511457A (sv)
AU (1) AU6840596A (sv)
CA (1) CA2228803A1 (sv)
SE (1) SE9502921D0 (sv)
WO (1) WO1997008188A1 (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7109360B1 (en) * 1999-02-09 2006-09-19 Schering Ag 16-hydroxyestratrienes as selectively active estrogens
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
US20050209208A1 (en) * 2001-04-25 2005-09-22 The Regents Of The University Of California Use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune disorders
WO2010050916A1 (en) * 2008-10-31 2010-05-06 The Regents Of The University Of California Estrogen receptor ligand treatment for neurodegenerative diseases
US6936599B2 (en) * 2001-04-25 2005-08-30 The Regents Of The University Of California Estriol therapy for multiple sclerosis and other autoimmune diseases
US8658627B2 (en) 2001-04-25 2014-02-25 The Regents Of The University Of California Pregnancy hormone combination for treatment of autoimmune diseases
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US7179798B2 (en) * 2001-11-16 2007-02-20 Russell R. Roby Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
PT1546719E (pt) * 2002-08-08 2015-07-02 Baylor College Medicine Isolamento e identificação de células t
US20050065136A1 (en) * 2003-08-13 2005-03-24 Roby Russell R. Methods and compositions for the treatment of infertility using dilute hormone solutions
SE527131C2 (sv) * 2004-02-13 2005-12-27 Innoventus Project Ab Steroider för cancerbehandling
US20050239757A1 (en) * 2004-04-21 2005-10-27 Roby Russell R Hormone treatment of macular degeneration
WO2005105107A2 (en) * 2004-04-21 2005-11-10 Roby Russell R Hormone treatment of multiple sclerosis
US20060025390A1 (en) * 2004-07-28 2006-02-02 Roby Russell R Treatment of hormone allergy and related symptoms and disorders
WO2006042172A2 (en) * 2004-10-09 2006-04-20 The Regents Of The University Of Michigan Gender differences in experimental aortic aneurysm formation
US8030298B2 (en) * 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
JP2009510084A (ja) 2005-09-26 2009-03-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 自己免疫及び神経変性疾患及び障害のためのエストリオール療法
CA2623905A1 (en) * 2005-09-26 2007-04-05 The Regents Of The University Of California Estriol therapy for autoimmune and neurodegenerative diseases and disorders
PL2420833T3 (pl) * 2006-05-05 2016-03-31 Opexa Therapeutics Szczepionka z komórek T
US8288367B2 (en) * 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
US8575141B2 (en) * 2007-10-30 2013-11-05 The Wistar Institute Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
US8669243B2 (en) * 2007-10-30 2014-03-11 The Wistar Institute Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741801A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-methylen-estratriene
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5371078A (en) * 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension

Also Published As

Publication number Publication date
WO1997008188A1 (en) 1997-03-06
AU6840596A (en) 1997-03-19
CA2228803A1 (en) 1997-03-06
JPH11511457A (ja) 1999-10-05
US6043236A (en) 2000-03-28
EP0847399A1 (en) 1998-06-17

Similar Documents

Publication Publication Date Title
SE9502921D0 (sv) New compounds
PT772603E (pt) Compostos substituidos de pirimidina e sua utilizacao
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
MY132529A (en) Paroxetine hydrochloride anhydrate
BR9812837A (pt) Processo para fazer um composto, e, composto
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
PT687260E (pt) Processo para a preparacao de 9-desoxotaxanos
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
FI973221A (sv) 1-aryl-2-acylammo-etanföreningar och användning därav som neurokininantagonister, särskilt som neurokinin 1 antagonister
BR9808923A (pt) Composto, e, processo para fazer o mesmo
FI964045A0 (sv) 5-heterocykliska 1,5-bensodiazepiner som reglerar CCK eller gastrin
DE69703796D1 (de) N-bis- oder n-tris-[(1,2-dicarboxy-ethoxy)-ethyl]-amin-derivate und herstellung und anwendung derselben
SE9501808D0 (sv) New process
GB9607034D0 (en) Chemical compounds
BR9807785A (pt) Processo para a preparação do composto, e, composto
NZ320522A (en) Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
ATE184305T1 (de) Monoazopigmente
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
SE9404438D0 (sv) New process
DE69414586D1 (de) Verfahren zur herstellung von indolizinderivaten
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
SE9401596D0 (sv) New compounds
ES2172699T3 (es) Procedimiento para la preparacion de prostaglandina e1.